Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 InterMune Names Chief Business Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

InterMune Names Chief Business Officer

Nolan to build U.S. commercial operations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sean P. Nolan has been appointed executive vice president and chief business officer at InterMune, Inc. In this newly created position, Mr. Nolan will lead the establishment of InterMune’s U.S. commercial, business development and global marketing groups. He will also oversee Canadian operations and the company’s manufacturing operations and supply chain management. Mr. Nolan will report to Dan Welch, chairman, chief executive officer and president of InterMune.
 
Mr. Nolan joins the company from Reata Pharmaceuticals, where he most recently served as vice president and chief commercial officer and built a commercial operation to support the company’s lead product.
 
Mr. Welch said, “Sean will play a key role in InterMune’s future as our Esbriet sales continue to grow globally, we move closer to the anticipated approval and launch of Esbriet [a treatment for idiopathic pulmonary fibrosis] in the U.S. and as we prepare to develop our business. I am confident that Sean will provide the broad and deep commercial and business experience, energy and drive that are essential during this exciting period of growth and change for our company.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics